Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial

2010740 citationsJournal Articlebronze Open Access

Authors

Danny Rischin

Richard J. Young · Palo Alto University

Richard Fisher · Peter MacCallum Cancer Centre

Stephen B. Fox · Palo Alto University

Quynh‐Thu Le · Peter MacCallum Cancer Centre

Lester J. Peters · Royal Brisbane and Women's Hospital

Benjamin Solomon · Palo Alto University

Abstract

HPV-associated oropharyngeal cancer is a distinct entity with a favorable prognosis compared with HPV-negative oropharyngeal cancer when treated with cisplatin-based chemoradiotherapy.

Topics & Keywords

Head and Neck Cancer Studies Head and Neck Surgical Oncology Cancer-related Molecular Pathways

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 28, Issue 27, pp. 4142-4148

DOI: 10.1200/jco.2010.29.2904

Field-Weighted Citation Impact: 42.69